Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature

• Main Authors: Tay, Sen Hee, Toh, Michelle Min Xuan, Thian, Yee Liang, Vellayappan, Balamurugan A, Fairhurst, Anna-Marie, Chan, Yiong Huak, Aminkeng, Folefac, Bharwani, Lavina D, Huang, Yiqing, Mak, Anselm, Wong, Alvin Seng Cheong
• Other Authors: DEAN'S OFFICE (MEDICINE)
• Format: Review
• Language: English
• Published: FRONTIERS MEDIA SA 2022
• Subjects: Science & Technology; Life Sciences & Biomedicine; Immunology; immunotherapy; immune-related adverse events; cytokine release syndrome; tocilizumab; immune checkpoint inhibitors; ADVERSE EVENTS; T-CELLS; IMMUNOTHERAPY; MANAGEMENT; TOXICITIES; DIAGNOSIS
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/235037
• Institution: National University of Singapore

10.3389/fimmu.2022.807050